Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 230

1.

Role of CB2 Receptor in the Recovery of Mice after Traumatic Brain Injury.

Magid L, Heymann S, Elgali M, Avram L, Cohen Y, Liraz-Zaltsman S, Mechoulam R, Shohami E.

J Neurotrauma. 2019 Feb 7. doi: 10.1089/neu.2018.6063. [Epub ahead of print]

PMID:
30489198
2.

Stimulation of N-methyl-D-aspartate receptors by exogenous and endogenous ligands improves outcome of brain injury.

Biegon A, Liraz-Zaltsman S, Shohami E.

Curr Opin Neurol. 2018 Dec;31(6):687-692. doi: 10.1097/WCO.0000000000000612.

PMID:
30382950
3.

Enhancement of Brain d-Serine Mediates Recovery of Cognitive Function after Traumatic Brain Injury.

Liraz-Zaltsman S, Slusher B, Atrakchi-Baranes D, Rosenblatt K, Friedman Levi Y, Kesner E, Silva AJ, Biegon A, Shohami E.

J Neurotrauma. 2018 Jul 15;35(14):1667-1680. doi: 10.1089/neu.2017.5561. Epub 2018 Apr 30.

PMID:
29648983
4.

Nerve growth factor plays a role in the neurotherapeutic effect of a CD45+ pan-hematopoietic subpopulation derived from human umbilical cord blood in a traumatic brain injury model.

Gincberg G, Shohami E, Trembovler V, Alexandrovich AG, Lazarovici P, Elchalal U.

Cytotherapy. 2018 Feb;20(2):245-261. doi: 10.1016/j.jcyt.2017.11.008. Epub 2017 Dec 20.

PMID:
29274773
5.
6.

Neuroinflammation-Induced Memory Deficits Are Amenable to Treatment with D-Cycloserine.

Liraz-Zaltsman S, Yaka R, Shabashov D, Shohami E, Biegon A.

J Mol Neurosci. 2016 Sep;60(1):46-62. doi: 10.1007/s12031-016-0786-8. Epub 2016 Jul 16.

PMID:
27421842
7.

Cannabinoids in Health and Disease.

Shohami E, Horowitz M.

J Basic Clin Physiol Pharmacol. 2016 May 1;27(3):175-9. doi: 10.1515/jbcpp-2016-0045. No abstract available.

8.

Are the endocannabinoid-like compounds N-acyl aminoacids neuroprotective after traumatic brain injury?

Mann A, Cohen-Yeshurun A, Trembovler V, Mechoulam R, Shohami E.

J Basic Clin Physiol Pharmacol. 2016 May 1;27(3):209-16. doi: 10.1515/jbcpp-2015-0092. Review.

9.

Heat acclimation provides sustained improvement in functional recovery and attenuates apoptosis after traumatic brain injury.

Umschweif G, Shein NA, Alexandrovich AG, Trembovler V, Horowitz M, Shohami E.

J Cereb Blood Flow Metab. 2015 Nov;35(11):1901. doi: 10.1038/jcbfm.2015.207. No abstract available.

10.

Molecular programs induced by heat acclimation confer neuroprotection against TBI and hypoxic insults via cross-tolerance mechanisms.

Horowitz M, Umschweif G, Yacobi A, Shohami E.

Front Neurosci. 2015 Jul 28;9:256. doi: 10.3389/fnins.2015.00256. eCollection 2015. Review.

11.

Palmitoyl Serine: An Endogenous Neuroprotective Endocannabinoid-Like Entity After Traumatic Brain Injury.

Mann A, Smoum R, Trembovler V, Alexandrovich A, Breuer A, Mechoulam R, Shohami E.

J Neuroimmune Pharmacol. 2015 Jun;10(2):356-63. doi: 10.1007/s11481-015-9595-z. Epub 2015 Feb 27.

PMID:
25721934
12.

Short term morphine exposure in vitro alters proliferation and differentiation of neural progenitor cells and promotes apoptosis via mu receptors.

Willner D, Cohen-Yeshurun A, Avidan A, Ozersky V, Shohami E, Leker RR.

PLoS One. 2014 Jul 29;9(7):e103043. doi: 10.1371/journal.pone.0103043. eCollection 2014.

13.

Ouabain improves functional recovery following traumatic brain injury.

Dvela-Levitt M, Ami HC, Rosen H, Shohami E, Lichtstein D.

J Neurotrauma. 2014 Dec 1;31(23):1942-7. doi: 10.1089/neu.2014.3544. Epub 2014 Oct 10.

14.

Angiotensin receptor type 2 activation induces neuroprotection and neurogenesis after traumatic brain injury.

Umschweif G, Liraz-Zaltsman S, Shabashov D, Alexandrovich A, Trembovler V, Horowitz M, Shohami E.

Neurotherapeutics. 2014 Jul;11(3):665-78. doi: 10.1007/s13311-014-0286-x.

15.

Neuroprotection after traumatic brain injury in heat-acclimated mice involves induced neurogenesis and activation of angiotensin receptor type 2 signaling.

Umschweif G, Shabashov D, Alexandrovich AG, Trembovler V, Horowitz M, Shohami E.

J Cereb Blood Flow Metab. 2014 Aug;34(8):1381-90. doi: 10.1038/jcbfm.2014.93. Epub 2014 May 21.

16.

N-Acyl amino acids and their impact on biological processes.

Hanuš L, Shohami E, Bab I, Mechoulam R.

Biofactors. 2014 Jul-Aug;40(4):381-8. doi: 10.1002/biof.1166. Epub 2014 Apr 21.

PMID:
24753374
17.

Neurotherapeutic effect of cord blood derived CD45+ hematopoietic cells in mice after traumatic brain injury.

Arien-Zakay H, Gincberg G, Nagler A, Cohen G, Liraz-Zaltsman S, Trembovler V, Alexandrovich AG, Matok I, Galski H, Elchalal U, Lelkes PI, Lazarovici P, Shohami E.

J Neurotrauma. 2014 Aug 15;31(16):1405-16. doi: 10.1089/neu.2013.3270. Epub 2014 Jul 14.

18.

Inosine improves functional recovery after experimental traumatic brain injury.

Dachir S, Shabashov D, Trembovler V, Alexandrovich AG, Benowitz LI, Shohami E.

Brain Res. 2014 Mar 25;1555:78-88. doi: 10.1016/j.brainres.2014.01.044. Epub 2014 Feb 3.

PMID:
24502983
19.

Novel approach to the role of NMDA receptors in traumatic brain injury.

Shohami E, Biegon A.

CNS Neurol Disord Drug Targets. 2014;13(4):567-73. Review.

PMID:
24168367
20.

The role and dynamics of β-catenin in precondition induced neuroprotection after traumatic brain injury.

Umschweif G, Alexandrovich AG, Trembovler V, Horowitz M, Shohami E.

PLoS One. 2013 Oct 4;8(10):e76129. doi: 10.1371/journal.pone.0076129. eCollection 2013.

21.

N-arachidonoyl-L-serine (AraS) possesses proneurogenic properties in vitro and in vivo after traumatic brain injury.

Cohen-Yeshurun A, Willner D, Trembovler V, Alexandrovich A, Mechoulam R, Shohami E, Leker RR.

J Cereb Blood Flow Metab. 2013 Aug;33(8):1242-50. doi: 10.1038/jcbfm.2013.75. Epub 2013 May 22.

22.

Hypoxia-inducible factor 1 is essential for spontaneous recovery from traumatic brain injury and is a key mediator of heat acclimation induced neuroprotection.

Umschweif G, Alexandrovich AG, Trembovler V, Horowitz M, Shohami E.

J Cereb Blood Flow Metab. 2013 Apr;33(4):524-31. doi: 10.1038/jcbfm.2012.193. Epub 2013 Jan 2.

23.

Carvacrol together with TRPC1 elimination improve functional recovery after traumatic brain injury in mice.

Peters M, Trembovler V, Alexandrovich A, Parnas M, Birnbaumer L, Minke B, Shohami E.

J Neurotrauma. 2012 Dec 10;29(18):2831-4. doi: 10.1089/neu.2012.2575. Epub 2012 Nov 16.

24.

Protective effects of incensole acetate on cerebral ischemic injury.

Moussaieff A, Yu J, Zhu H, Gattoni-Celli S, Shohami E, Kindy MS.

Brain Res. 2012 Mar 14;1443:89-97. doi: 10.1016/j.brainres.2012.01.001. Epub 2012 Jan 9.

25.

Combination of vascular endothelial and fibroblast growth factor 2 for induction of neurogenesis and angiogenesis after traumatic brain injury.

Thau-Zuchman O, Shohami E, Alexandrovich AG, Leker RR.

J Mol Neurosci. 2012 May;47(1):166-72. doi: 10.1007/s12031-012-9706-8. Epub 2012 Jan 13.

PMID:
22246995
26.

Subacute treatment with vascular endothelial growth factor after traumatic brain injury increases angiogenesis and gliogenesis.

Thau-Zuchman O, Shohami E, Alexandrovich AG, Leker RR.

Neuroscience. 2012 Jan 27;202:334-41. doi: 10.1016/j.neuroscience.2011.11.071. Epub 2011 Dec 6.

PMID:
22173016
27.

Inactivation of PKMζ in the NAc shell abolished cocaine-conditioned reward.

Shabashov D, Shohami E, Yaka R.

J Mol Neurosci. 2012 Jul;47(3):546-53. doi: 10.1007/s12031-011-9671-7. Epub 2011 Nov 30.

PMID:
22127928
28.

Near infrared transcranial laser therapy applied at various modes to mice following traumatic brain injury significantly reduces long-term neurological deficits.

Oron A, Oron U, Streeter J, De Taboada L, Alexandrovich A, Trembovler V, Shohami E.

J Neurotrauma. 2012 Jan 20;29(2):401-7. doi: 10.1089/neu.2011.2062. Epub 2012 Jan 4.

PMID:
22040267
29.

The anti-inflammatory drug carprofen improves long-term outcome and induces gliogenesis after traumatic brain injury.

Thau-Zuchman O, Shohami E, Alexandrovich AG, Trembovler V, Leker RR.

J Neurotrauma. 2012 Jan 20;29(2):375-84. doi: 10.1089/neu.2010.1673. Epub 2011 Aug 29.

PMID:
21561314
30.

N-arachidonoyl-L-serine is neuroprotective after traumatic brain injury by reducing apoptosis.

Cohen-Yeshurun A, Trembovler V, Alexandrovich A, Ryberg E, Greasley PJ, Mechoulam R, Shohami E, Leker RR.

J Cereb Blood Flow Metab. 2011 Aug;31(8):1768-77. doi: 10.1038/jcbfm.2011.53. Epub 2011 Apr 20.

31.

Endocannabinoids and traumatic brain injury.

Shohami E, Cohen-Yeshurun A, Magid L, Algali M, Mechoulam R.

Br J Pharmacol. 2011 Aug;163(7):1402-10. doi: 10.1111/j.1476-5381.2011.01343.x. Review.

32.

Administration of 2-arachidonoylglycerol ameliorates both acute and chronic experimental autoimmune encephalomyelitis.

Lourbopoulos A, Grigoriadis N, Lagoudaki R, Touloumi O, Polyzoidou E, Mavromatis I, Tascos N, Breuer A, Ovadia H, Karussis D, Shohami E, Mechoulam R, Simeonidou C.

Brain Res. 2011 May 16;1390:126-41. doi: 10.1016/j.brainres.2011.03.020. Epub 2011 Mar 13.

PMID:
21406188
33.

Histone deacetylase inhibitors as therapeutic agents for acute central nervous system injuries.

Shein NA, Shohami E.

Mol Med. 2011 May-Jun;17(5-6):448-56. doi: 10.2119/molmed.2011.00038. Epub 2011 Jan 25. Review.

34.

Regional sensitivity to neuroinflammation: in vivo and in vitro studies.

Liraz-Zaltsman S, Alexandrovich AG, Trembovler V, Fishbein I, Yaka R, Shohami E, Biegon A.

Synapse. 2011 Jul;65(7):634-42. doi: 10.1002/syn.20889. Epub 2011 Feb 25.

35.

CB2 cannabinoid receptor targets mitogenic Gi protein-cyclin D1 axis in osteoblasts.

Ofek O, Attar-Namdar M, Kram V, Dvir-Ginzberg M, Mechoulam R, Zimmer A, Frenkel B, Shohami E, Bab I.

J Bone Miner Res. 2011 Feb;26(2):308-16. doi: 10.1002/jbmr.228.

36.

Vascular endothelial growth factor increases neurogenesis after traumatic brain injury.

Thau-Zuchman O, Shohami E, Alexandrovich AG, Leker RR.

J Cereb Blood Flow Metab. 2010 May;30(5):1008-16. doi: 10.1038/jcbfm.2009.271. Epub 2010 Jan 13.

37.

D-cycloserine improves functional outcome after traumatic brain injury with wide therapeutic window.

Adeleye A, Shohami E, Nachman D, Alexandrovich A, Trembovler V, Yaka R, Shoshan Y, Dhawan J, Biegon A.

Eur J Pharmacol. 2010 Mar 10;629(1-3):25-30. doi: 10.1016/j.ejphar.2009.11.066. Epub 2009 Dec 1.

38.

Heat acclimation provides sustained improvement in functional recovery and attenuates apoptosis after traumatic brain injury.

Umscheif G, Shein NA, Alexandrovich AG, Trembovler V, Horowitz M, Shohami E.

J Cereb Blood Flow Metab. 2010 Mar;30(3):616-27. doi: 10.1038/jcbfm.2009.234. Epub 2009 Nov 11. Erratum in: J Cereb Blood Flow Metab. 2015 Nov;35(11):1901. Umschwief, Gali [corrected to Umschweif, Gali].

39.

Histone deacetylase inhibitor ITF2357 is neuroprotective, improves functional recovery, and induces glial apoptosis following experimental traumatic brain injury.

Shein NA, Grigoriadis N, Alexandrovich AG, Simeonidou C, Lourbopoulos A, Polyzoidou E, Trembovler V, Mascagni P, Dinarello CA, Shohami E.

FASEB J. 2009 Dec;23(12):4266-75. doi: 10.1096/fj.09-134700. Epub 2009 Sep 1.

40.

Mouse closed head injury model induced by a weight-drop device.

Flierl MA, Stahel PF, Beauchamp KM, Morgan SJ, Smith WR, Shohami E.

Nat Protoc. 2009;4(9):1328-37. doi: 10.1038/nprot.2009.148. Epub 2009 Aug 27.

PMID:
19713954
41.

CD38 facilitates recovery from traumatic brain injury.

Levy A, Bercovich-Kinori A, Alexandrovich AG, Tsenter J, Trembovler V, Lund FE, Shohami E, Stein R, Mayo L.

J Neurotrauma. 2009 Sep;26(9):1521-33. doi: 10.1089/neu.2008.0746.

42.

Microglial involvement in neuroprotection following experimental traumatic brain injury in heat-acclimated mice.

Shein NA, Grigoriadis N, Horowitz M, Umschwief G, Alexandrovich AG, Simeonidou C, Grigoriadis S, Touloumi O, Shohami E.

Brain Res. 2008 Dec 9;1244:132-41. doi: 10.1016/j.brainres.2008.09.032. Epub 2008 Sep 19.

PMID:
18835383
43.

Pharmacology of traumatic brain injury: where is the "golden bullet"?

Beauchamp K, Mutlak H, Smith WR, Shohami E, Stahel PF.

Mol Med. 2008 Nov-Dec;14(11-12):731-40. doi: 10.2119/2008-00050.Beauchamp. Epub 2008 Aug 18. Review.

44.

Incensole acetate, an incense component, elicits psychoactivity by activating TRPV3 channels in the brain.

Moussaieff A, Rimmerman N, Bregman T, Straiker A, Felder CC, Shoham S, Kashman Y, Huang SM, Lee H, Shohami E, Mackie K, Caterina MJ, Walker JM, Fride E, Mechoulam R.

FASEB J. 2008 Aug;22(8):3024-34. doi: 10.1096/fj.07-101865. Epub 2008 May 20.

45.

Targeting cell death in vivo in experimental traumatic brain injury by a novel molecular probe.

Reshef A, Shirvan A, Shohami E, Grimberg H, Levin G, Cohen A, Trembovler V, Ziv I.

J Neurotrauma. 2008 Jun;25(6):569-80. doi: 10.1089/neu.2007.0341.

PMID:
18447626
46.

Incensole acetate: a novel neuroprotective agent isolated from Boswellia carterii.

Moussaieff A, Shein NA, Tsenter J, Grigoriadis S, Simeonidou C, Alexandrovich AG, Trembovler V, Ben-Neriah Y, Schmitz ML, Fiebich BL, Munoz E, Mechoulam R, Shohami E.

J Cereb Blood Flow Metab. 2008 Jul;28(7):1341-52. doi: 10.1038/jcbfm.2008.28. Epub 2008 Apr 16.

PMID:
18414499
47.

Dynamic changes in the recovery after traumatic brain injury in mice: effect of injury severity on T2-weighted MRI abnormalities, and motor and cognitive functions.

Tsenter J, Beni-Adani L, Assaf Y, Alexandrovich AG, Trembovler V, Shohami E.

J Neurotrauma. 2008 Apr;25(4):324-33. doi: 10.1089/neu.2007.0452.

PMID:
18373482
48.

Differential neuroprotective properties of endogenous and exogenous erythropoietin in a mouse model of traumatic brain injury.

Shein NA, Grigoriadis N, Alexandrovich AG, Simeonidou C, Spandou E, Tsenter J, Yatsiv I, Horowitz M, Shohami E.

J Neurotrauma. 2008 Feb;25(2):112-23. doi: 10.1089/neu.2007.0358.

PMID:
18260794
49.

Increased expression of the gamma-secretase components presenilin-1 and nicastrin in activated astrocytes and microglia following traumatic brain injury.

Nadler Y, Alexandrovich A, Grigoriadis N, Hartmann T, Rao KS, Shohami E, Stein R.

Glia. 2008 Apr;56(5):552-67. doi: 10.1002/glia.20638.

PMID:
18240300
50.

Altered cytokine expression and sustained hypothermia following traumatic brain injury in heat acclimated mice.

Shein NA, Doron H, Horowitz M, Trembovler V, Alexandrovich AG, Shohami E.

Brain Res. 2007 Dec 14;1185:313-20. Epub 2007 Sep 20.

PMID:
17963735

Supplemental Content

Loading ...
Support Center